HMO-offered DM programs are in transition, according to Art Taft, president of MedWorks, a DM consulting firm in Greensboro, N.C.
HMO-offered DM programs are in transition, according to Art Taft, president of MedWorks, a DM consulting firm in Greensboro, N.C.
"The measured evidence suggests that these programs are providing positive results, but the difficulty in calculating the exact benefit make an absolute conclusion unlikely," Taft says. "To date, HMO executives have apparently decided to focus generally on disease states with defined NCQA requirements that ensure that the programs produce definite value, albeit in plan accreditation or in higher HEDIS measures." However, this situation is about to change, Taft says. "Patient-centered care models have always been challenged by patients with more than one chronic condition," he says. "There has also been a continuing overlap between disease management and other HMO services including nurseline services, case and utilization management, employee-assistance offerings, lifestyle programs and Web services, to name but a few. This combination of medical management services is both inefficient and ineffective. Patients can become confused when they are engaged by multiple HMO offerings, the messages provided by the different services may be inconsistent, and the cost of maintaining and managing these different infrastructures is not insignificant."
Employers are asking HMOs to build an integrated care management infrastructure, according to Taft. "These environments will use one information system infrastructure that coordinates all of a patient's care issues, whether they have a chronic illness or a acute event-or both," he says. "HMO executives should realize they are being asked to step up to the plate and truly manage patient care for the long term." "In the future, we'll see DM entities becoming more involved at the employer level to offer new and innovative offerings around less chronic disease states, as well as new methods of home monitoring and interaction," according to Thomas Young, MD, senior vice president, corporate medical director for Connextions Health, an Orlando, Fla.-based provider of integrated healthcare services solutions.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More